Allianz Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-16,684
| Closed | -$60K | – | 2175 |
|
2021
Q4 | $60K | Sell |
16,684
-10
| -0.1% | -$36 | ﹤0.01% | 2058 |
|
2021
Q3 | $61K | Buy |
16,694
+1,380
| +9% | +$5.04K | ﹤0.01% | 2008 |
|
2021
Q2 | $67K | Buy |
15,314
+177
| +1% | +$774 | ﹤0.01% | 1882 |
|
2021
Q1 | $62K | Sell |
15,137
-2,953
| -16% | -$12.1K | ﹤0.01% | 1877 |
|
2020
Q4 | $72K | Sell |
18,090
-1,351
| -7% | -$5.38K | ﹤0.01% | 1811 |
|
2020
Q3 | $52K | Sell |
19,441
-5,751
| -23% | -$15.4K | ﹤0.01% | 1786 |
|
2020
Q2 | $69K | Sell |
25,192
-365,715
| -94% | -$1M | ﹤0.01% | 1850 |
|
2020
Q1 | $923K | Sell |
390,907
-3,251
| -0.8% | -$7.68K | ﹤0.01% | 1475 |
|
2019
Q4 | $1.85M | Buy |
394,158
+10,752
| +3% | +$50.5K | ﹤0.01% | 1485 |
|
2019
Q3 | $1.28M | Sell |
383,406
-461,697
| -55% | -$1.54M | ﹤0.01% | 1603 |
|
2019
Q2 | $2.78M | Buy |
845,103
+337
| +0% | +$1.11K | ﹤0.01% | 1442 |
|
2019
Q1 | $2.56M | Sell |
844,766
-8,167
| -1% | -$24.7K | ﹤0.01% | 1488 |
|
2018
Q4 | $2.32M | Sell |
852,933
-38,353
| -4% | -$104K | ﹤0.01% | 1426 |
|
2018
Q3 | $3M | Buy |
891,286
+132,113
| +17% | +$444K | ﹤0.01% | 1455 |
|
2018
Q2 | $1.96M | Sell |
759,173
-3,838
| -0.5% | -$9.9K | ﹤0.01% | 1532 |
|
2018
Q1 | $1.68M | Sell |
763,011
-13,193
| -2% | -$29K | ﹤0.01% | 1562 |
|
2017
Q4 | $1.55M | Sell |
776,204
-10,036
| -1% | -$20K | ﹤0.01% | 1609 |
|
2017
Q3 | $2.55M | Buy |
786,240
+12,402
| +2% | +$40.2K | ﹤0.01% | 1413 |
|
2017
Q2 | $2.49M | Buy |
+773,838
| New | +$2.49M | ﹤0.01% | 1412 |
|
2014
Q3 | – | Sell |
-400,000
| Closed | -$1.07M | – | 1988 |
|
2014
Q2 | $1.07M | Sell |
400,000
-1,435,234
| -78% | -$3.83M | ﹤0.01% | 1364 |
|
2014
Q1 | $6.42M | Buy |
1,835,234
+132,080
| +8% | +$462K | 0.01% | 872 |
|
2013
Q4 | $7.63M | Buy |
1,703,154
+193,528
| +13% | +$867K | 0.01% | 815 |
|
2013
Q3 | $6.13M | Buy |
1,509,626
+49,471
| +3% | +$201K | 0.01% | 840 |
|
2013
Q2 | $6.07M | Buy |
+1,460,155
| New | +$6.07M | 0.01% | 808 |
|